Global Prescription Medicine Key Trends and Opportunities to 2027

Global Prescription Medicine Key Trends and Opportunities to 2027

Report Code: KNJ781066 | No. of Pages: 202 | Category: Pharmaceuticals and Healthcare
Publisher: QYResearch | Date of Publish: Jun-2021
Prescription Medicine market is segmented by companies, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prescription Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on market size and forecast for the period 2016-2027.
Segment by Type, the Prescription Medicine market is segmented into Original Brand Drug, Generic Drug, etc.
Segment by Application, the Prescription Medicine market is segmented into Hospital, Clinic, Online, Others, etc.

Regional and Country-level Analysis
The report offers exhaustive assessment of different region-wise and country-wise Prescription Medicine markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Turkey, etc.
The report includes country-wise and region-wise market size for the period 2016-2027, by countries (regions), by Type, and by Application, as well as by players for North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Competitive Landscape and Prescription Medicine Market Share Analysis
Prescription Medicine market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2016-2021. Details included are company description, major business, company total revenue and revenue generated in Prescription Medicine business, the date to enter into the Prescription Medicine market, Prescription Medicine product introduction, recent developments, etc.
The major vendors include Pfizer, Roche, Novartis, Johnson & Johnson, Merck & Co., Sanofi, AbbVie, GlaxoSmithKline, Amgen, Gilead Science, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Bayer, Novo Nordisk, Takeda, Boehringer-Ingelheim, Allergan, Teva Pharmaceutical Industries, Mylan, etc.
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prescription Medicine Market Size by Type: 2016 VS 2021 VS 2027
        1.2.2 Original Brand Drug
        1.2.3 Generic Drug
    1.3 Market by Application
        1.3.1 Global Prescription Medicine Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Online
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trend
    2.1 Global Prescription Medicine Market Perspective (2016-2027)
    2.2 Global Prescription Medicine Growth Trends by Regions
        2.2.1 Prescription Medicine Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Prescription Medicine Historic Market Size by Regions (2016-2021)
        2.2.3 Prescription Medicine Forecasted Market Size by Regions (2022-2027)
    2.3 Industry Trends and Growth Strategy
        2.3.1 Prescription Medicine Industry Trends
        2.3.2 Prescription Medicine Market Drivers
        2.3.3 Prescription Medicine Market Challenges
        2.3.4 Prescription Medicine Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Prescription Medicine Players by Market Size
        3.1.1 Players Covered: Ranking by Prescription Medicine Revenue
        3.1.2 Global Top Prescription Medicine Players by Revenue (2016-2021)
        3.1.3 Global Prescription Medicine Revenue Market Share by Players (2016-2021)
        3.1.4 Global Prescription Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.2 Global Prescription Medicine Market Concentration Ratio
        3.2.1 Global Prescription Medicine Market Concentration Ratio (CR5 and HHI)
        3.2.2 Global Top 5 and Top 10 Players by Prescription Medicine Revenue in 2020
    3.3 Prescription Medicine Key Players Head office and Area Served
    3.4 Key Players Prescription Medicine Product Solution and Service
    3.5 Date of Enter into Prescription Medicine Market
    3.6 Mergers & Acquisitions, Expansion Plans

4 Global Prescription Medicine Breakdown Data by Type (2016-2027)
    4.1 Global Prescription Medicine Historic Market Size by Type (2016-2021)
    4.2 Global Prescription Medicine Forecasted Market Size by Type (2022-2027)

5 Global Prescription Medicine Breakdown Data by Application (2016-2027)
    5.1 Global Prescription Medicine Historic Market Size by Application (2016-2021)
    5.2 Prescription Medicine Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Prescription Medicine Market Size (2016-2027)
    6.2 Key Prescription Medicine Players Market Share in North America (2020-2021)
    6.3 North America Prescription Medicine Market Size by Country
        6.3.1 North America Prescription Medicine Sales by Country (2016-2021)
        6.3.2 North America Prescription Medicine Market Size Forecast by Country (2022-2027)
    6.4 U.S. Market Size Analysis
        6.4.1 U.S. Prescription Medicine Market Size (2016-2027)
        6.4.2 U.S. Prescription Medicine Market Size by Type (2016-2027)
        6.4.3 U.S. Prescription Medicine Market Size by Application (2016-2027)
    6.5 Canada Market Size Analysis
        6.5.1 Canada Prescription Medicine Market Size (2016-2027)
        6.5.2 Canada Prescription Medicine Market Size by Type (2016-2027)
        6.5.3 Canada Prescription Medicine Market Size by Application (2016-2027)
7 Europe
    7.1 Europe Prescription Medicine Market Size (2016-2027)
    7.2 Key Prescription Medicine Players Market Share in Europe (2020-2021)
    7.3 Europe Prescription Medicine Market Size by Country
        7.3.1 Europe Prescription Medicine Sales by Country (2016-2021)
        7.3.2 Europe Prescription Medicine Market Size Forecast by Country (2022-2027)
    7.4 Germany Market Size Analysis
        7.4.1 Germany Prescription Medicine Market Size (2016-2027)
        7.4.2 Germany Prescription Medicine Market Size by Type (2016-2027)
        7.4.3 Germany Prescription Medicine Market Size by Application (2016-2027)
    7.5 France Market Size Analysis
        7.5.1 France Prescription Medicine Market Size (2016-2027)
        7.5.2 France Prescription Medicine Market Size by Type (2016-2027)
        7.5.3 France Prescription Medicine Market Size by Application (2016-2027)
    7.6 U.K. Market Size Analysis
        7.6.1 U.K. Prescription Medicine Market Size (2016-2027)
        7.6.2 U.K. Prescription Medicine Market Size by Type (2016-2027)
        7.6.3 U.K. Prescription Medicine Market Size by Application (2016-2027)
    7.7 Italy Market Size Analysis
        7.7.1 Italy Prescription Medicine Market Size (2016-2027)
        7.7.2 Italy Prescription Medicine Market Size by Type (2016-2027)
        7.7.3 Italy Prescription Medicine Market Size by Application (2016-2027)
    7.8 Russia Market Size Analysis
        7.8.1 Russia Prescription Medicine Market Size (2016-2027)
        7.8.2 Russia Prescription Medicine Market Size by Type (2016-2027)
        7.8.3 Russia Prescription Medicine Market Size by Application (2016-2027)
8 Asia-Pacific
    8.1 Asia-Pacific Prescription Medicine Market Size (2016-2027)
    8.2 Key Prescription Medicine Players Market Share in Asia-Pacific (2020-2021)
    8.3 Asia-Pacific Prescription Medicine Market Size by Region
        8.3.1 Asia-Pacific Prescription Medicine Sales by Region (2016-2021)
        8.3.2 Asia-Pacific Prescription Medicine Market Size Forecast by Region (2022-2027)
    8.4 China Market Size Analysis
        8.4.1 China Prescription Medicine Market Size (2016-2027)
        8.4.2 China Prescription Medicine Market Size by Type (2016-2027)
        8.4.3 China Prescription Medicine Market Size by Application (2016-2027)
    8.5 Japan Market Size Analysis
        8.5.1 Japan Prescription Medicine Market Size (2016-2027)
        8.5.2 Japan Prescription Medicine Market Size by Type (2016-2027)
        8.5.3 Japan Prescription Medicine Market Size by Application (2016-2027)
    8.6 South Korea Market Size Analysis
        8.6.1 South Korea Prescription Medicine Market Size (2016-2027)
        8.6.2 South Korea Prescription Medicine Market Size by Type (2016-2027)
        8.6.3 South Korea Prescription Medicine Market Size by Application (2016-2027)
    8.7 India Market Size Analysis
        8.7.1 India Prescription Medicine Market Size (2016-2027)
        8.7.2 India Prescription Medicine Market Size by Type (2016-2027)
        8.7.3 India Prescription Medicine Market Size by Application (2016-2027)
    8.8 Australia Market Size Analysis
        8.8.1 Australia Prescription Medicine Market Size (2016-2027)
        8.8.2 Australia Prescription Medicine Market Size by Type (2016-2027)
        8.8.3 Australia Prescription Medicine Market Size by Application (2016-2027)
    8.9 Taiwan Market Size Analysis
        8.9.1 Taiwan Prescription Medicine Market Size (2016-2027)
        8.9.2 Taiwan Prescription Medicine Market Size by Type (2016-2027)
        8.9.3 Taiwan Prescription Medicine Market Size by Application (2016-2027)
    8.10 Indonesia Market Size Analysis
        8.10.1 Indonesia Prescription Medicine Market Size (2016-2027)
        8.10.2 Indonesia Prescription Medicine Market Size by Type (2016-2027)
        8.10.3 Indonesia Prescription Medicine Market Size by Application (2016-2027)
    8.11 Thailand Market Size Analysis
        8.11.1 Thailand Prescription Medicine Market Size (2016-2027)
        8.11.2 Thailand Prescription Medicine Market Size by Type (2016-2027)
        8.11.3 Thailand Prescription Medicine Market Size by Application (2016-2027)
    8.12 Malaysia Market Size Analysis
        8.12.1 Malaysia Prescription Medicine Market Size (2016-2027)
        8.12.2 Malaysia Prescription Medicine Market Size by Type (2016-2027)
        8.12.3 Malaysia Prescription Medicine Market Size by Application (2016-2027)
    8.13 Philippines Market Size Analysis
        8.13.1 Philippines Prescription Medicine Market Size (2016-2027)
        8.13.2 Philippines Prescription Medicine Market Size by Type (2016-2027)
        8.13.3 Philippines Prescription Medicine Market Size by Application (2016-2027)
    8.14 Vietnam Market Size Analysis
        8.14.1 Vietnam Prescription Medicine Market Size (2016-2027)
        8.14.2 Vietnam Prescription Medicine Market Size by Type (2016-2027)
        8.14.3 Vietnam Prescription Medicine Market Size by Application (2016-2027)
9 Latin America
    9.1 Latin America Prescription Medicine Market Size (2016-2027)
    9.2 Key Prescription Medicine Players Market Share in Latin America (2020-2021)
    9.3 Latin America Prescription Medicine Market Size by Country
        9.3.1 Latin America Prescription Medicine Sales by Country (2016-2021)
        9.3.2 Latin America Prescription Medicine Market Size Forecast by Country (2022-2027)
    9.4 Mexico Market Size Analysis
        9.4.1 Mexico Prescription Medicine Market Size (2016-2027)
        9.4.2 Mexico Prescription Medicine Market Size by Type (2016-2027)
        9.4.3 Mexico Prescription Medicine Market Size by Application (2016-2027)
    9.5 Brazil Market Size Analysis
        9.5.1 Brazil Prescription Medicine Market Size (2016-2027)
        9.5.2 Brazil Prescription Medicine Market Size by Type (2016-2027)
        9.5.3 Brazil Prescription Medicine Market Size by Application (2016-2027)
    9.6 Argentina Market Size Analysis
        9.6.1 Argentina Prescription Medicine Market Size (2016-2027)
        9.6.2 Argentina Prescription Medicine Market Size by Type (2016-2027)
        9.6.3 Argentina Prescription Medicine Market Size by Application (2016-2027)
10 Middle East & Africa
    10.1 Middle East & Africa Prescription Medicine Market Size (2016-2027)
    10.2 Key Prescription Medicine Players Market Share in Middle East & Africa (2020-2021)
    10.3 Middle East & Africa Prescription Medicine Market Size by Country
        10.3.1 Middle East & Africa Prescription Medicine Sales by Country (2016-2021)
        10.3.2 Middle East & Africa Prescription Medicine Market Size Forecast by Country (2022-2027)
    10.4 Turkey Market Size Analysis
        10.4.1 Turkey Prescription Medicine Market Size (2016-2027)
        10.4.2 Turkey Prescription Medicine Market Size by Type (2016-2027)
        10.4.3 Turkey Prescription Medicine Market Size by Application (2016-2027)
    10.5 Saudi Arabia Market Size Analysis
        10.5.1 Saudi Arabia Prescription Medicine Market Size (2016-2027)
        10.5.2 Saudi Arabia Prescription Medicine Market Size by Type (2016-2027)
        10.5.3 Saudi Arabia Prescription Medicine Market Size by Application (2016-2027)
    10.6 UAE Market Size Analysis
        10.6.1 UAE Prescription Medicine Market Size (2016-2027)
        10.6.2 UAE Prescription Medicine Market Size by Type (2016-2027)
        10.6.3 UAE Prescription Medicine Market Size by Application (2016-2027)

11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview and Its Total Revenue
        11.1.3 Pfizer Prescription Medicine Introduction
        11.1.4 Pfizer Revenue in Prescription Medicine Business (2016-2021)
        11.1.5 Pfizer Recent Development
    11.2 Roche
        11.2.1 Roche Company Details
        11.2.2 Roche Business Overview and Its Total Revenue
        11.2.3 Roche Prescription Medicine Introduction
        11.2.4 Roche Revenue in Prescription Medicine Business (2016-2021)
        11.2.5 Roche Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview and Its Total Revenue
        11.3.3 Novartis Prescription Medicine Introduction
        11.3.4 Novartis Revenue in Prescription Medicine Business (2016-2021)
        11.3.5 Novartis Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview and Its Total Revenue
        11.4.3 Johnson & Johnson Prescription Medicine Introduction
        11.4.4 Johnson & Johnson Revenue in Prescription Medicine Business (2016-2021)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Merck & Co.
        11.5.1 Merck & Co. Company Details
        11.5.2 Merck & Co. Business Overview and Its Total Revenue
        11.5.3 Merck & Co. Prescription Medicine Introduction
        11.5.4 Merck & Co. Revenue in Prescription Medicine Business (2016-2021)
        11.5.5 Merck & Co. Recent Development
    11.6 Sanofi
        11.6.1 Sanofi Company Details
        11.6.2 Sanofi Business Overview and Its Total Revenue
        11.6.3 Sanofi Prescription Medicine Introduction
        11.6.4 Sanofi Revenue in Prescription Medicine Business (2016-2021)
        11.6.5 Sanofi Recent Development
    11.7 AbbVie
        11.7.1 AbbVie Company Details
        11.7.2 AbbVie Business Overview and Its Total Revenue
        11.7.3 AbbVie Prescription Medicine Introduction
        11.7.4 AbbVie Revenue in Prescription Medicine Business (2016-2021)
        11.7.5 AbbVie Recent Development
    11.8 GlaxoSmithKline
        11.8.1 GlaxoSmithKline Company Details
        11.8.2 GlaxoSmithKline Business Overview and Its Total Revenue
        11.8.3 GlaxoSmithKline Prescription Medicine Introduction
        11.8.4 GlaxoSmithKline Revenue in Prescription Medicine Business (2016-2021)
        11.8.5 GlaxoSmithKline Recent Development
    11.9 Amgen
        11.9.1 Amgen Company Details
        11.9.2 Amgen Business Overview and Its Total Revenue
        11.9.3 Amgen Prescription Medicine Introduction
        11.9.4 Amgen Revenue in Prescription Medicine Business (2016-2021)
        11.9.5 Amgen Recent Development
    11.10 Gilead Science
        11.10.1 Gilead Science Company Details
        11.10.2 Gilead Science Business Overview and Its Total Revenue
        11.10.3 Gilead Science Prescription Medicine Introduction
        11.10.4 Gilead Science Revenue in Prescription Medicine Business (2016-2021)
        11.10.5 Gilead Science Recent Development
    11.11 Bristol-Myers Squibb
        11.11.1 Bristol-Myers Squibb Company Details
        11.11.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
        11.11.3 Bristol-Myers Squibb Prescription Medicine Introduction
        11.11.4 Bristol-Myers Squibb Revenue in Prescription Medicine Business (2016-2021)
        11.11.5 Bristol-Myers Squibb Recent Development
    11.12 AstraZeneca
        11.12.1 AstraZeneca Company Details
        11.12.2 AstraZeneca Business Overview and Its Total Revenue
        11.12.3 AstraZeneca Prescription Medicine Introduction
        11.12.4 AstraZeneca Revenue in Prescription Medicine Business (2016-2021)
        11.12.5 AstraZeneca Recent Development
    11.13 Eli Lilly
        11.13.1 Eli Lilly Company Details
        11.13.2 Eli Lilly Business Overview and Its Total Revenue
        11.13.3 Eli Lilly Prescription Medicine Introduction
        11.13.4 Eli Lilly Revenue in Prescription Medicine Business (2016-2021)
        11.13.5 Eli Lilly Recent Development
    11.14 Bayer
        11.14.1 Bayer Company Details
        11.14.2 Bayer Business Overview and Its Total Revenue
        11.14.3 Bayer Prescription Medicine Introduction
        11.14.4 Bayer Revenue in Prescription Medicine Business (2016-2021)
        11.14.5 Bayer Recent Development
    11.15 Novo Nordisk
        11.15.1 Novo Nordisk Company Details
        11.15.2 Novo Nordisk Business Overview and Its Total Revenue
        11.15.3 Novo Nordisk Prescription Medicine Introduction
        11.15.4 Novo Nordisk Revenue in Prescription Medicine Business (2016-2021)
        11.15.5 Novo Nordisk Recent Development
    11.16 Takeda
        11.16.1 Takeda Company Details
        11.16.2 Takeda Business Overview and Its Total Revenue
        11.16.3 Takeda Prescription Medicine Introduction
        11.16.4 Takeda Revenue in Prescription Medicine Business (2016-2021)
        11.16.5 Takeda Recent Development
    11.17 Boehringer-Ingelheim
        11.17.1 Boehringer-Ingelheim Company Details
        11.17.2 Boehringer-Ingelheim Business Overview and Its Total Revenue
        11.17.3 Boehringer-Ingelheim Prescription Medicine Introduction
        11.17.4 Boehringer-Ingelheim Revenue in Prescription Medicine Business (2016-2021)
        11.17.5 Boehringer-Ingelheim Recent Development
    11.18 Allergan
        11.18.1 Allergan Company Details
        11.18.2 Allergan Business Overview and Its Total Revenue
        11.18.3 Allergan Prescription Medicine Introduction
        11.18.4 Allergan Revenue in Prescription Medicine Business (2016-2021)
        11.18.5 Allergan Recent Development
    11.19 Teva Pharmaceutical Industries
        11.19.1 Teva Pharmaceutical Industries Company Details
        11.19.2 Teva Pharmaceutical Industries Business Overview and Its Total Revenue
        11.19.3 Teva Pharmaceutical Industries Prescription Medicine Introduction
        11.19.4 Teva Pharmaceutical Industries Revenue in Prescription Medicine Business (2016-2021)
        11.19.5 Teva Pharmaceutical Industries Recent Development
    11.20 Mylan
        11.20.1 Mylan Company Details
        11.20.2 Mylan Business Overview and Its Total Revenue
        11.20.3 Mylan Prescription Medicine Introduction
        11.20.4 Mylan Revenue in Prescription Medicine Business (2016-2021)
        11.20.5 Mylan Recent Development
    11.21 Astellas Pharma
        11.21.1 Astellas Pharma Company Details
        11.21.2 Astellas Pharma Business Overview and Its Total Revenue
        11.21.3 Astellas Pharma Prescription Medicine Introduction
        11.21.4 Astellas Pharma Revenue in Prescription Medicine Business (2016-2021)
        11.21.5 Astellas Pharma Recent Development
    11.22 Biogen
        11.22.1 Biogen Company Details
        11.22.2 Biogen Business Overview and Its Total Revenue
        11.22.3 Biogen Prescription Medicine Introduction
        11.22.4 Biogen Revenue in Prescription Medicine Business (2016-2021)
        11.22.5 Biogen Recent Development
    11.23 CSL
        11.23.1 CSL Company Details
        11.23.2 CSL Business Overview and Its Total Revenue
        11.23.3 CSL Prescription Medicine Introduction
        11.23.4 CSL Revenue in Prescription Medicine Business (2016-2021)
        11.23.5 CSL Recent Development
    11.24 Daiichi Sankyo
        11.24.1 Daiichi Sankyo Company Details
        11.24.2 Daiichi Sankyo Business Overview and Its Total Revenue
        11.24.3 Daiichi Sankyo Prescription Medicine Introduction
        11.24.4 Daiichi Sankyo Revenue in Prescription Medicine Business (2016-2021)
        11.24.5 Daiichi Sankyo Recent Development
    11.25 Otsuka Holdings
        11.25.1 Otsuka Holdings Company Details
        11.25.2 Otsuka Holdings Business Overview and Its Total Revenue
        11.25.3 Otsuka Holdings Prescription Medicine Introduction
        11.25.4 Otsuka Holdings Revenue in Prescription Medicine Business (2016-2021)
        11.25.5 Otsuka Holdings Recent Development
    11.26 UCB
        11.26.1 UCB Company Details
        11.26.2 UCB Business Overview and Its Total Revenue
        11.26.3 UCB Prescription Medicine Introduction
        11.26.4 UCB Revenue in Prescription Medicine Business (2016-2021)
        11.26.5 UCB Recent Development
    11.27 LES LABORATOIRES SERVIER
        11.27.1 LES LABORATOIRES SERVIER Company Details
        11.27.2 LES LABORATOIRES SERVIER Business Overview and Its Total Revenue
        11.27.3 LES LABORATOIRES SERVIER Prescription Medicine Introduction
        11.27.4 LES LABORATOIRES SERVIER Revenue in Prescription Medicine Business (2016-2021)
        11.27.5 LES LABORATOIRES SERVIER Recent Development
    11.28 Bausch Health Companies
        11.28.1 Bausch Health Companies Company Details
        11.28.2 Bausch Health Companies Business Overview and Its Total Revenue
        11.28.3 Bausch Health Companies Prescription Medicine Introduction
        11.28.4 Bausch Health Companies Revenue in Prescription Medicine Business (2016-2021)
        11.28.5 Bausch Health Companies Recent Development
    11.29 Eisai
        11.29.1 Eisai Company Details
        11.29.2 Eisai Business Overview and Its Total Revenue
        11.29.3 Eisai Prescription Medicine Introduction
        11.29.4 Eisai Revenue in Prescription Medicine Business (2016-2021)
        11.29.5 Eisai Recent Development
    11.30 Abbott Laboratories
        11.30.1 Abbott Laboratories Company Details
        11.30.2 Abbott Laboratories Business Overview and Its Total Revenue
        11.30.3 Abbott Laboratories Prescription Medicine Introduction
        11.30.4 Abbott Laboratories Revenue in Prescription Medicine Business (2016-2021)
        11.30.5 Abbott Laboratories Recent Development

12 Analyst's Viewpoints/Conclusion
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com